TL;DR
This study investigates how the COVID-19 pandemic and subsequent lockdown in Hubei Province, China, impacted the medical-seeking patterns and daily behaviors of hematopoietic stem-cell transplant (HSCT) recipients. It reveals a significant shift towards online consultations and self-management of symptoms, alongside increased adoption of protective measures, highlighting the adaptability of this vulnerable patient group.
What Problem Does This Paper Address?
Hematopoietic stem-cell transplant (HSCT) recipients are a particularly vulnerable population due to their compromised immune systems, making them susceptible to severe infections and complications. The COVID-19 pandemic presented a unique challenge for these individuals, as it necessitated strict public health measures like lockdowns, which could disrupt regular medical follow-ups, drug procurement, and access to healthcare. This paper addresses the critical question of how these disruptions affected the medical-seeking patterns and daily behaviors of HSCT recipients in Hubei Province during the COVID-19 lockdown, and whether these changes impacted their health outcomes. Understanding these adaptations is crucial for developing effective strategies to manage vulnerable patient populations during future public health crises.
Methods
The researchers conducted a multicenter, cross-sectional, web-based investigation using online questionnaires. This survey was administered to HSCT recipients in Hubei Province between April 25 and May 30, 2020. Participants were recruited through WeChat and a medical app called "DoctorWith." The study collected data on demographic characteristics, primary disease, HSCT complications, self-perceived health status, daily behavior, and their experiences with COVID-19, including difficulties faced and fears during the epidemic. Two questionnaires were used: one for the COVID-19 epidemic period and another for the pre-epidemic period, allowing for a comparative analysis. Statistical analysis involved descriptive statistics, independent samples t-tests, Mann-Whitney tests, Kruskal-Wallis tests, chi-squared tests, and Fisher's exact tests to compare data between the pre-epidemic and during-epidemic groups.
Datasets
The study utilized data collected from 145 HSCT recipients who completed both pre-epidemic and during-epidemic questionnaires. This dataset comprised demographic information, medical history, and self-reported behaviors and experiences related to the COVID-19 pandemic. No new public datasets were introduced.
Key Insights and Ideas
- Adaptability of HSCT Recipients: Despite their vulnerability, HSCT recipients demonstrated significant adaptability in their medical-seeking patterns and daily behaviors during the lockdown.
- Shift to Digital Healthcare: The pandemic accelerated the adoption of telemedicine, with a notable increase in online consultations for influenza-like symptoms.
- Challenges in Drug Access: A significant proportion of patients experienced difficulties in purchasing medications, leading to strategies like online purchasing or drug withdrawal.
- Heightened Protective Measures: There was a dramatic increase in mask-wearing and home isolation, indicating a strong emphasis on personal protection.
- Impact on Routine Care: Regular medical re-examinations saw a sharp decline, which was identified as a major source of anxiety for patients.
Key Results
- During the lockdown, 40% of patients opted for self-medication with oral drugs, and 23.33% consulted physicians online or by telephone for influenza-like symptoms, a significant shift from the pre-epidemic preference for hospital visits (68.29%).
- A substantial majority (64.83%) faced difficulties purchasing drugs during the epidemic, compared to 24.83% before. To cope, 23.40% preferred online purchasing, and 18.09% chose to decrease or withdraw their medications.
- The number of participants undergoing regular re-examinations decreased significantly during the epidemic.
- Mask-wearing increased by 17.24%, and outdoor activities decreased substantially (from 49.66% to 16.55%).
- Interestingly, there was no statistically significant difference in the incidence of graft-versus-host disease (GVHD) complications between the pre-epidemic and during-epidemic periods.
- Six HSCT recipients were diagnosed with COVID-19, with half of them succumbing to the illness due to related complications.
Limitations and Future Work
The authors acknowledge several limitations:
- Small Sample Size: The study's sample size of 145 participants is relatively small, which may limit the generalizability of the findings. However, they note that this size is comparable to other influential studies in the field.
- Selection Bias: The overrepresentation of younger and middle-aged participants (due to the primary user base of the communication platforms used) might lead to selection bias.
- Early Pandemic Diagnosis: The diagnosis of COVID-19 was based on guidelines from the early epidemic phase, which may have involved empirical diagnoses and lacked molecular confirmation in some cases.
- Blinding: The reliance on patient families for questionnaires in some cases meant blinding to the intervention was not possible.
Future work suggested by the authors includes:
- Larger Cohort Studies: Conducting studies with larger cohorts to confirm the initial findings and assess their transferability to other at-risk populations.
- Telemedicine Evaluation: Further research is needed to evaluate the long-term availability and effectiveness of telemedicine in managing HSCT recipients, especially as the epidemic normalizes.
- Long-term Complications: Investigating the long-term impact of the pandemic-induced changes on HSCT complications and overall patient outcomes.
Summary updated